Hematologic Malignancy
Plasma Cell Neoplasm with Associated Paraneoplastic Syndrome
CI-CAN-00008251Explore in graph →
HematologicNon-malignant1 active trials
- NCIt
- C200738
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00008251Explore in graph →
Clinical trials
4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02921893 | Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome | completed | Early Phase 1 | 21 | Mayo ClinicOTHER | 1 | Feb 12, 2025 | clinicaltrials |
| NCT04561557 | Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System(CARTinNS) | recruiting | Early Phase 1 | 36 | Tongji HospitalOTHER | 1 | Oct 30, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Feb 12, 2025source: clinicaltrials